Previous close | 0.3500 |
Open | 0.2500 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 70.00 |
Expiry date | 2024-05-17 |
Day's range | 0.2500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 5.29k |
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences: 2024 RBC Capital Markets Global Healthcare ConferenceTuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY Bank of America Healthcare Conference 2024Thursday, May 16, 2024 at 9:20 a.m. PT (12:2